α-Mangostin Shows Chemopreventive Activity in Benzo[a]pyrene-induced Lung Cancer in Mice Via Regulation of Apoptosis and Tumor Biomarkers
Yuan Feng1, Jinxiu Guo2, Chao Wang3, Zonglin Shi3★★ Corresponding author
- 1Department of Pharmacy, The Eighth Hospital of Wuhan, Wuhan, Hubei, CHINA.
- 2Department of Tuberculosis, Yantai Qishan Hospital, Yantai, Shandong, CHINA.
- 3Department of Medical Oncology, Ankang Hospital of Traditional Chinese Medicine, Ankang, Shaanxi, CHINA.
CORRESPONDENCE
Zonglin Shi
Department of Medical Oncology, Ankang Hospital of Traditional Chinese Medicine, Ankang, Shaanxi, CHINA.
Received: 13-01-2025; Accepted: 24-03-2025.
Volume 22, Issue 1 · pp. 289–299 · PUBLISHED 2026 · DOI: 10.1177/09731296251341499
View on Pharmacogn. Mag. original site ↗
ABSTRACT
Background: Lung cancer is a serious disease affecting millions of individuals globally, defined by the unregulated proliferation of abnormal cells in the lungs. It is the primary cause of cancer-associated fatalities worldwide, representing a significant portion of cancer incidence and mortality rates. Objectives: This work was dedicated to assessing the anti-cancer activity of α-mangostin against benzo[a]pyrene (B[a]P)-induced lung cancer in mice model. Materials and Methods: Lung tumorigenesis was initiated in Swiss mice with oral treatment of B[a]P for 4 consecutive weeks. Mice were treated with α-mangostin following B[a]P induction in mice for 16 weeks. The body and lung weights and tumor incidences were assessed in the experimental mice after the conclusion of the treatments. The concentrations of oxidant and antioxidant markers, tumor biomarkers, mitochondrial enzymes, and apoptotic protein markers in the experimental mice were assessed using the commercial diagnostic kits. The immunohistochemical analysis was performed on the lung tissues to assess the expression of the proliferating cell nuclear antigen (PCNA) protein. Results: Both pre- and post-treatments of α-mangostin (25 mg/kg) significantly enhanced body weight while reducing lung weight and tumor incidences in the B[a]P-induced mice. The α-mangostin treatment effectively increased the antioxidants and vitamins and diminished the tumor biomarker concentrations in the mice with lung cancer. Furthermore, the α-mangostin treatment considerably increased the mitochondrial enzyme concentrations and regulated the apoptotic proteins in the lung tissues of B[a]P-induced mice. In addition, the PCNA protein expression was reduced by the α-mangostin treatment in the lung tissues. Conclusion: In conclusion, our findings demonstrate that α-mangostin exhibits chemopreventive properties in lung cancer initiated by B[a]P in mice, suggesting its potential to enhance chemotherapy approaches for lung cancer.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Feng, Y., Guo, J., Wang, C., & Shi, Z. (2026). α-Mangostin Shows Chemopreventive Activity in Benzo[a]pyrene-induced Lung Cancer in Mice Via Regulation of Apoptosis and Tumor Biomarkers. Pharmacognosy Magazine, 22(1), 289–299. https://doi.org/10.1177/09731296251341499
